Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Cash from Operations (2016 - 2018)

Historic Cash from Operations for Armata Pharmaceuticals (ARMP) over the last 6 years, with Q4 2018 value amounting to -$3.2 million.

  • Armata Pharmaceuticals' Cash from Operations fell 3486.7% to -$3.2 million in Q4 2018 from the same period last year, while for Dec 2018 it was -$10.6 million, marking a year-over-year decrease of 1561.14%. This contributed to the annual value of -$37.6 million for FY2024, which is 2081.69% up from last year.
  • Per Armata Pharmaceuticals' latest filing, its Cash from Operations stood at -$3.2 million for Q4 2018, which was down 3486.7% from -$2.0 million recorded in Q3 2018.
  • Armata Pharmaceuticals' Cash from Operations' 5-year high stood at -$593000.0 during Q3 2017, with a 5-year trough of -$3.7 million in Q1 2014.
  • Its 5-year average for Cash from Operations is -$2.6 million, with a median of -$2.8 million in 2015.
  • Its Cash from Operations has fluctuated over the past 5 years, first skyrocketed by 8106.04% in 2017, then crashed by 24064.08% in 2018.
  • Over the past 5 years, Armata Pharmaceuticals' Cash from Operations (Quarter) stood at -$3.2 million in 2014, then rose by 27.59% to -$2.3 million in 2015, then skyrocketed by 35.35% to -$1.5 million in 2016, then crashed by 58.14% to -$2.4 million in 2017, then tumbled by 34.87% to -$3.2 million in 2018.
  • Its Cash from Operations was -$3.2 million in Q4 2018, compared to -$2.0 million in Q3 2018 and -$1.9 million in Q2 2018.